COL2A1 and synovial sarcoma: While most individuals with pathogenic COL2A1 variants will exhibit systemic manifestations of SS, individuals harboring pathogenic variants in exon 2 will exhibit an ocular-only phenotype due to alternative splicing of the gene [18,19].